Aimei Health Technology Co., Ltd. is an innovative leader in the healthcare technology sector, focused on transforming health solutions through cutting-edge digital platforms and medical devices. The company is at the forefront of the burgeoning telehealth and personalized medicine markets, utilizing advanced artificial intelligence and data analytics to improve patient outcomes and optimize healthcare delivery. Aimei's strategic commitment to innovation not only enhances operational efficiency within healthcare systems but also positions the company for significant growth and a pivotal role in shaping the future landscape of healthcare technology.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.04% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.56 |
| Price-to-Book | 6.70 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -30.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $6.12M |
| Float | $4.40M |
| % Insiders | 33.60% |
| % Institutions | 19.18% |
Volatility is currently contracting